These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21504301)

  • 21. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
    Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
    Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
    Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.
    Vieira E; Maia HS; Monteiro CB; Carvalho LM; Tonon T; Vanz AP; Schwartz IVD; Ribeiro MG
    Braz J Med Biol Res; 2017 Dec; 51(2):e6709. PubMed ID: 29267500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insurance Reimbursement for Special Foods and Phenylalanine Levels in Patients With PKU in China.
    Wang B; Xia Y; Cheng M; Luo H; Xue L; Gong A; Liu X; Liao G; Song J; Ning K
    JAMA Netw Open; 2024 Jun; 7(6):e2412886. PubMed ID: 38837161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Work activity and phenylalanine levels in a population of young adults with classic PKU.
    Riva MA; Madotto F; Turato M; Salvatici E; Indovina S; Giovannini M; Riva E; Cesana G
    Med Lav; 2017 Apr; 108(2):118-122. PubMed ID: 28446738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of sapropterin on urinary monoamine metabolites in phenylketonuria.
    Douglas TD; Jinnah HA; Bernhard D; Singh RH
    Mol Genet Metab; 2013 Jul; 109(3):243-50. PubMed ID: 23712020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term efficacy of 'ready-to-drink' protein substitute in phenylketonuria.
    Gokmen-Ozel H; MacDonald A; Daly A; Hall K; Ryder L; Chakrapani A
    J Hum Nutr Diet; 2009 Oct; 22(5):422-7. PubMed ID: 19743980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body mass index in adult patients with diet-treated phenylketonuria.
    Robertson LV; McStravick N; Ripley S; Weetch E; Donald S; Adam S; Micciche A; Boocock S; MacDonald A
    J Hum Nutr Diet; 2013 Jul; 26 Suppl 1():1-6. PubMed ID: 23551621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individualized long-term outcomes in blood phenylalanine concentrations and dietary phenylalanine tolerance in 11 patients with primary phenylalanine hydroxylase (PAH) deficiency treated with Sapropterin-dihydrochloride.
    Stockler-Ipsiroglu S; Yuskiv N; Salvarinova R; Apatean D; Ho G; Cheng B; Giezen A; Lillquist Y; Ueda K
    Mol Genet Metab; 2015 Mar; 114(3):409-14. PubMed ID: 25497838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult patients with well-controlled phenylketonuria tolerate incidental additional intake of phenylalanine.
    van Rijn M; Hoeksma M; Sauer PJ; Modderman P; Reijngoud DJ; van Spronsen FJ
    Ann Nutr Metab; 2011; 58(2):94-100. PubMed ID: 21474926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does maternal knowledge impact blood phenylalanine concentration in Turkish children with phenylketonuria?
    Ozel HG; Kucukkasap T; Koksal G; Sivri HS; Dursun A; Tokatli A; Coskun T
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S213-7. PubMed ID: 18581253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre.
    Altman G; Hussain K; Green D; Strauss BJG; Wilcox G
    Orphanet J Rare Dis; 2021 Dec; 16(1):520. PubMed ID: 34930395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU).
    Burton BK; Bausell H; Katz R; Laduca H; Sullivan C
    Mol Genet Metab; 2010; 101(2-3):110-4. PubMed ID: 20638313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of phenylketonuria for optimal outcome: a review of guidelines for phenylketonuria management and a report of surveys of parents, patients, and clinic directors.
    Wappner R; Cho S; Kronmal RA; Schuett V; Seashore MR
    Pediatrics; 1999 Dec; 104(6):e68. PubMed ID: 10586002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioural factors related to metabolic control in patients with phenylketonuria.
    Crone MR; van Spronsen FJ; Oudshoorn K; Bekhof J; van Rijn G; Verkerk PH
    J Inherit Metab Dis; 2005; 28(5):627-37. PubMed ID: 16151893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The maternal phenylketonuria syndrom--still current problem].
    Didycz B; Domagała L; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenylketonuria is not a risk factor for gut mucosa inflammation: a preliminary observation.
    Walkowiak J; Cofta S; Mozrzymas R; Siwinska-Mrozek Z; Nowak J; Kaluzny L; Banasiewicz T
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):3056-9. PubMed ID: 24302186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.